- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01156376
Oral Irritation Study of Two Experimental Mouthrinses
Determination of the Oral Irritation and Sensitization Potential of Two Experimental Potassium Oxalate Containing Mouthrinses
Study Overview
Status
Conditions
Detailed Description
This is a randomized, observer-blind, single-center, supervised, controlled, parallel-designed study. Approximately 90 generally healthy adults meeting the necessary inclusion/exclusion criteria will be enrolled so that 78 subjects (26 per treatment group) would reasonably be expected to complete the study. Subjects will have their oral soft/hard tissues assessed at Screening (visit 1), Baseline (visit 2), and Days 3, 5, 24, and 25 (visits 4,6-8). During the first week of the study, subjects will be instructed to brush their teeth for one minute in their usual manner, twice daily using the provided standard fluoride toothpaste. Subjects will return for the Baseline exam and, upon qualification with entry criteria, will be assigned to one of three treatment groups. Qualified subjects will be instructed to return to the site for five consecutive days. Subjects will have four supervised rinses with their assigned mouth rinse for either 30 or 60 seconds using 10 ml or 20 ml, at subsequent one-hour intervals. During the 5 consecutive days of exposure to the assigned mouthrinse, subjects will brush their teeth using the provided fluoride-free toothpaste and soft-bristled toothbrush.
Subjects will then have an 18-day rest period (off treatment). During this time, subjects will follow their usual oral hygiene and dietary habits, using the standard fluoride toothpaste and soft toothbrush provided, and must refrain from using any unassigned oral care products. On the 19th day after completion of Day 5 (Day 24), subjects will return for an oral examination. If no pathology is present, subjects will be given a challenge treatment (four supervised rinses) and the final oral examination will be performed on Day 25.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Indiana
-
Fort Wayne, Indiana, United States, 46825
- University Park Research Center (UPRC)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Males and females at least 18 years of age in good general and oral health without any known allergy to commercial dental products or cosmetics.
- Evidence of a personally signed and dated informed consent document indicating the subject (or legally acceptable representative) has been informed of all pertinent aspects of the trial.
- Willingness to use the assigned products according to instructions, availability for appointments, and likelihood of completing the clinical trial.
- Willingness to refrain from using any breath freshener products (e.g., oral care strips, candy-type mints, sprays, chewing gums, throat lozenges, cough drops or mouthwashes), whitening products and smokeless tobacco products within one week prior to and for the duration of the study, in order to reduce alternate sources of potential irritation and sensitization.
- A minimum of 20 natural teeth.
- Absence of abnormal or severe fissured tongue, geographic tongue, or any obvious tongue abnormalities that may interfere with the assessment of oral irritation.
- Adequate oral hygiene (i.e., brush teeth daily & exhibit no signs of oral neglect).
- Absence of neglected dental health (i.e., gross calculus deposits or rampant caries based on visual examination), significant oral soft tissue pathology, systematically-related gingival enlargement or tissue damage due to ill-fitting appliances or restoration.
- Absence of orthodontic bands, appliances, bridges, extensive large restorations or removable orthodontic appliances.
Exclusion Criteria:
- Volunteers who report history or presence of kidney disorders or kidney stones, Crohn's Disease or other malabsorption syndromes.
- History of significant adverse effects following use of oral hygiene products such as toothpastes and mouthwashes.
- Physical limitations or restrictions that might preclude use of normal oral hygiene procedures (i.e., toothbrushing, mouthrinsing, etc.).
- History or current evidence of significant oral soft tissue pathology, excluding gingivitis, based on the dentist's visual examination and at the discretion of the investigator.
- Those requiring antibiotic premedication prior to dental treatment.
- Participation in a dental clinical trial involving oral care products within the past 30 days.
- Visual evidence of Moderate/Advanced Periodontitis (ADA Type III, IV).
- Women who are pregnant, nursing or plan to become pregnant during the course of the study.
- Volunteers requiring treatment with Indinavir or loop diuretics (i.e., Furosemide).
- Other severe, acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with trial participation or may interfere with the interpretation of trial result and, in the judgment of the investigator, would make the subject inappropriate for entry into this trial
- Any clinical history which in the opinion of the investigator could compromise the safety of the subject or the clinical parameters being assessed
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: PO-019
Formula 12027-019 Mouthwash
|
1.40% Potassium Oxalate Sensitive Mouthwash without fluoride - Rinse with 10ml for 60 seconds, four times daily successively at 1 hour intervals for five days
Other Names:
|
|
Experimental: PO-020
Formula 12027-020 Mouthwash
|
1.40% Potassium Oxalate Sensitive Mouthwash with fluoride - Rinse with 20ml for 60 seconds, four times daily successively at 1 hour intervals for five days
Other Names:
|
|
Active Comparator: PO-116-A
Cool Mint Listerine
|
Rinse with comparator mouthwash 20ml for 30 seconds, four times daily successively at 1 hour intervals for five days
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of Participants With an Abnormal Condition by Anatomical Site at Screening
Time Frame: Screening
|
Buccal, labial and sublingual mucosae, mucobuccal fold, gingiva, tongue, hard and soft palate, uvula, oropharynx, teeth and dental restorations were examined.
The dental examiner evaluated any condition as either normal or abnormal.
|
Screening
|
|
Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Baseline/Pretreatment
Time Frame: Day 1 - Baseline/Pretreatment
|
Buccal, labial and sublingual mucosae, mucobuccal fold, gingiva, tongue, hard and soft palate, uvula, oropharynx, teeth and dental restorations were examined.
The dental examiner evaluated any condition as either normal or abnormal.
|
Day 1 - Baseline/Pretreatment
|
|
Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 1 - Post-treatment
Time Frame: Day 1 - Post-treatment
|
Buccal, labial and sublingual mucosae, mucobuccal fold, gingiva, tongue, hard and soft palate, uvula, oropharynx, teeth and dental restorations were examined.
The dental examiner evaluated any condition as either normal or abnormal.
|
Day 1 - Post-treatment
|
|
Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 3
Time Frame: Day 3
|
Buccal, labial and sublingual mucosae, mucobuccal fold, gingiva, tongue, hard and soft palate, uvula, oropharynx, teeth and dental restorations were examined.
The dental examiner evaluated any condition as either normal or abnormal.
|
Day 3
|
|
Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 5
Time Frame: Day 5
|
Buccal, labial and sublingual mucosae, mucobuccal fold, gingiva, tongue, hard and soft palate, uvula, oropharynx, teeth and dental restorations were examined.
The dental examiner evaluated any condition as either normal or abnormal.
|
Day 5
|
|
Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Pretreatment
Time Frame: Day 24 - Pretreatment
|
Buccal, labial and sublingual mucosae, mucobuccal fold, gingiva, tongue, hard and soft palate, uvula, oropharynx, teeth and dental restorations were examined.
The dental examiner evaluated any condition as either normal or abnormal.
|
Day 24 - Pretreatment
|
|
Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 24 - Post-treatment
Time Frame: Day 24 - Post-treatment
|
Buccal, labial and sublingual mucosae, mucobuccal fold, gingiva, tongue, hard and soft palate, uvula, oropharynx, teeth and dental restorations were examined.
The dental examiner evaluated any condition as either normal or abnormal.
|
Day 24 - Post-treatment
|
|
Percentage of Participants With an Abnormal Condition by Anatomical Site at Day 25
Time Frame: Day 25
|
Buccal, labial and sublingual mucosae, mucobuccal fold, gingiva, tongue, hard and soft palate, uvula, oropharynx, teeth and dental restorations were examined.
The dental examiner evaluated any condition as either normal or abnormal.
|
Day 25
|
|
Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Screening
Time Frame: Screening
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Screening
|
|
Percentage of Subjects in Irritation Score Category for Labial Mucosa at Screening
Time Frame: Screening
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Screening
|
|
Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Screening
Time Frame: Screening
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Screening
|
|
Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Screening
Time Frame: Screening
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Screening
|
|
Percentage of Subjects in Irritation Score Category for Gingiva at Screening
Time Frame: Screening
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Screening
|
|
Percentage of Subjects in Irritation Score Category for Tongue at Screening
Time Frame: Screening
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Screening
|
|
Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Screening
Time Frame: Screening
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Screening
|
|
Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Screening
Time Frame: Screening
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Screening
|
|
Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Baseline/Pretreatment
Time Frame: Day 1 - Baseline/Pretreatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 1 - Baseline/Pretreatment
|
|
Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Baseline/Pretreatment
Time Frame: Day 1 - Baseline/Pretreatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 1 - Baseline/Pretreatment
|
|
Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Baseline/Pretreatment
Time Frame: Day 1 - Baseline/Pretreatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 1 - Baseline/Pretreatment
|
|
Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Baseline/Pretreatment
Time Frame: Day 1 - Baseline/Pretreatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 1 - Baseline/Pretreatment
|
|
Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Baseline/Pretreatment
Time Frame: Day 1 - Baseline/Pretreatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 1 - Baseline/Pretreatment
|
|
Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Baseline/Pretreatment
Time Frame: Day 1 - Baseline/Pretreatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 1 - Baseline/Pretreatment
|
|
Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Baseline/Pretreatment
Time Frame: Day 1 - Baseline/Pretreatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 1 - Baseline/Pretreatment
|
|
Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Baseline/Pretreatment
Time Frame: Day 1 - Baseline/Pretreatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 1 - Baseline/Pretreatment
|
|
Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 1 - Post-treatment
Time Frame: Day 1 - Post-treatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 1 - Post-treatment
|
|
Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 1 - Post-treatment
Time Frame: Day 1 - Post-treatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 1 - Post-treatment
|
|
Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 1 - Post-treatment
Time Frame: Day 1 - Post-treatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 1 - Post-treatment
|
|
Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 1 - Post-treatment
Time Frame: Day 1 - Post-treatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 1 - Post-treatment
|
|
Percentage of Subjects in Irritation Score Category for Gingiva at Day 1 - Post-treatment
Time Frame: Day 1 - Post-treatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 1 - Post-treatment
|
|
Percentage of Subjects in Irritation Score Category for Tongue at Day 1 - Post-treatment
Time Frame: Day 1 - Post-treatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 1 - Post-treatment
|
|
Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 1 - Post-treatment
Time Frame: Day 1 - Post-treatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 1 - Post-treatment
|
|
Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 1 - Post-treatment
Time Frame: Day 1 - Post-treatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 1 - Post-treatment
|
|
Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 3
Time Frame: Day 3
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 3
|
|
Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 3
Time Frame: Day 3
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 3
|
|
Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 3
Time Frame: Day 3
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 3
|
|
Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 3
Time Frame: Day 3
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 3
|
|
Percentage of Subjects in Irritation Score Category for Gingiva at Day 3
Time Frame: Day 3
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 3
|
|
Percentage of Subjects in Irritation Score Category for Tongue at Day 3
Time Frame: Day 3
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 3
|
|
Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 3
Time Frame: Day 3
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 3
|
|
Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 3
Time Frame: Day 3
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 3
|
|
Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 5
Time Frame: Day 5
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 5
|
|
Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 5
Time Frame: Day 5
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 5
|
|
Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 5
Time Frame: Day 5
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 5
|
|
Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 5
Time Frame: Day 5
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 5
|
|
Percentage of Subjects in Irritation Score Category for Gingiva at Day 5
Time Frame: Day 5
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 5
|
|
Percentage of Subjects in Irritation Score Category for Tongue at Day 5
Time Frame: Day 5
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 5
|
|
Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 5
Time Frame: Day 5
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 5
|
|
Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 5
Time Frame: Day 5
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 5
|
|
Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Pretreatment
Time Frame: Day 24 - Pretreatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 24 - Pretreatment
|
|
Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Pretreatment
Time Frame: Day 24 - Pretreatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 24 - Pretreatment
|
|
Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Pretreatment
Time Frame: Day 24 - Pretreatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 24 - Pretreatment
|
|
Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Pretreatment
Time Frame: Day 24 - Pretreatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 24 - Pretreatment
|
|
Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Pretreatment
Time Frame: Day 24 - Pretreatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 24 - Pretreatment
|
|
Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Pretreatment
Time Frame: Day 24 - Pretreatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 24 - Pretreatment
|
|
Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Pretreatment
Time Frame: Day 24 - Pretreatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 24 - Pretreatment
|
|
Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Pretreatment
Time Frame: Day 24 - Pretreatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 24 - Pretreatment
|
|
Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 24 - Post-treatment
Time Frame: Day 24 - Post-treatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 24 - Post-treatment
|
|
Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 24 - Post-treatment
Time Frame: Day 24 - Post-treatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 24 - Post-treatment
|
|
Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 24 - Post-treatment
Time Frame: Day 24 - Post-treatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 24 - Post-treatment
|
|
Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 24 - Post-treatment
Time Frame: Day 24 - Post-treatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 24 - Post-treatment
|
|
Percentage of Subjects in Irritation Score Category for Gingiva at Day 24 - Post-treatment
Time Frame: Day 24 - Post-treatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 24 - Post-treatment
|
|
Percentage of Subjects in Irritation Score Category for Tongue at Day 24 - Post-treatment
Time Frame: Day 24 - Post-treatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 24 - Post-treatment
|
|
Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 24 - Post-treatment
Time Frame: Day 24 - Post-treatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 24 - Post-treatment
|
|
Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 24 - Post-treatment
Time Frame: Day 24 - Post-treatment
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 24 - Post-treatment
|
|
Percentage of Subjects in Irritation Score Category for Buccal Mucosa at Day 25
Time Frame: Day 25
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 25
|
|
Percentage of Subjects in Irritation Score Category for Labial Mucosa at Day 25
Time Frame: Day 25
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 25
|
|
Percentage of Subjects in Irritation Score Category for Sublingual Mucosa at Day 25
Time Frame: Day 25
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 25
|
|
Percentage of Subjects in Irritation Score Category for Mucobuccal Fold at Day 25
Time Frame: Day 25
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 25
|
|
Percentage of Subjects in Irritation Score Category for Gingiva at Day 25
Time Frame: Day 25
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 25
|
|
Percentage of Subjects in Irritation Score Category for Tongue at Day 25
Time Frame: Day 25
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 25
|
|
Percentage of Subjects in Irritation Score Category for Hard/Soft Palate at Day 25
Time Frame: Day 25
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 25
|
|
Percentage of Subjects in Irritation Score Category for Uvula/Oropharynx at Day 25
Time Frame: Day 25
|
The dental examiner rated the irritation/inflammation on the soft tissues using a scale where 0=none (normal), 1=erythema plus slight edema (mild), 2=moderate erythema and/or edema (beginning of tissue breakdown or sloughing) (moderate), 3=severe inflammation/irritation (definite blistering, ulceration, or epithelial sloughing) (severe).
|
Day 25
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KOXDHY0003
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oral Manifestations
-
Grupo de Estudos Multicentricos em Onco-HematologiaRio de Janeiro State Research Supporting Foundation (FAPERJ)Unknown
-
Cairo UniversityNot yet recruitingChemotherapy Effect | Mucositis Oral
-
Fernanda Muñoz SepúlvedaSubvención Presidencial, Ministerio de Hacienda, Chile; Centro Interuniversitario... and other collaboratorsCompletedOral Health Knowledge | Oral Health Attitudes | Oral Health Self-efficacyChile
-
SeptodontSymatese; EndoData; Recherche Clinique en Odontologie (ReCOL)CompletedOral HemorrhageBelgium, France
-
Alberto Dal MolinAzienda Ospedaliero Universitaria Maggiore della CaritaCompletedNursing Education | Oral Cavity | Nursing Care | Oral Hygiene, Oral HealthItaly
-
University Medical Center GoettingenCompletedOral Hygiene, Oral HealthGermany
-
Alexandria UniversityCompletedOral Hygiene | Oral HealthEgypt
-
Alexandria UniversityRecruitingOral Hygiene | Oral Health LiteracyEgypt
-
Aminu Kano Teaching HospitalNIH Office of AIDS Research (OAR); Fogarty International Center of the National...CompletedQuality of Life | Dental Caries | HIV | Oral Disease | Oral Infection | Oral ManifestationsNigeria
-
Egas Moniz - Cooperativa de Ensino Superior, CRLCompleted
Clinical Trials on Potassium Oxalate without Fluoride
-
Johnson & Johnson Consumer and Personal Products...Completed
-
Federal University of UberlandiaCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Fundação de Amparo...UnknownDentin Sensitivity | Dentin Hypersensitivity | Dentine Hypersensitivity | Hypersensitivity DentinBrazil
-
Procter and GambleCompletedDentinal HypersensitivityUnited States
-
Procter and GambleCompletedDentin SensitivityUnited States
-
Procter and GambleCompletedDentin SensitivityUnited States
-
Procter and GambleCompleted
-
GlaxoSmithKlineCompletedDentin SensitivityUnited States
-
Johnson & Johnson Consumer and Personal Products...CompletedDentin SensitivityUnited States
-
Procter and GambleCompletedDentin SensitivityUnited States
-
Procter and GambleCompletedDentin SensitivityUnited States